文献速递肝病消化道肿瘤与早癌

酒精相关肝病所致肝细胞癌与其他病因所致肝细胞癌的差异

Differences between hepatocellular carcinoma caused by alcohol and other aetiologies.
PubMed 文献 · J Hepatol · 2024-12-20

酒精相关肝病是全球第三大及欧洲首要的肝细胞癌病因,MetALD(代谢功能障碍相关脂肪性肝病伴酒精摄入增加)将丰富该人群表型。此类患者诊断常延迟且筛查检出率低,确诊时一般状况差、肝功能受损重、合并症多,竞争性死亡增加;但监测中诊断者一线治愈性治疗分配率达56%,与病毒相关肝细胞癌相当。病因并非独立预后因素,预后由肝功能、一般状况和肿瘤负荷驱动。

要点

  • 酒精相关肝病是全球第三大及欧洲首要肝细胞癌病因,MetALD将丰富该人群表型。
  • 酒精相关肝细胞癌诊断常延迟、筛查检出率低,确诊时一般状况差、肝功能受损重、合并症多。
  • 监测中诊断的酒精相关肝细胞癌一线治愈性治疗分配率达56%,与病毒相关肝细胞癌相当。

核心结论

  • 肝硬化病因不能被视为肝细胞癌患者的独立预后因素,预后由肝功能、一般状况和肿瘤负荷驱动。
  • 在酒精相关肝病或MetALD相关肝硬化患者中,通过周期性监测早期诊断具有关键作用。

研究设计与样本

  • 本文为关于酒精相关肝细胞癌与其他病因所致肝细胞癌差异的综述。
  • 文章未报告系统检索范围。

主要发现

  • 酒精相关肝病是全球第三大肝细胞癌病因,在欧洲为首要病因。
  • 酒精相关肝细胞癌诊断常延迟,通过筛查项目检出的频率较低。
  • 确诊时酒精相关肝细胞癌患者一般状况较差、肝功能受损更重、合并症患病率更高,导致竞争性死亡增加。
  • 在监测项目中诊断的酒精相关肝病或MetALD患者中,一线治愈性治疗分配率为56%,与病毒相关肝细胞癌患者相当。

关键数值与推荐

  • 监测中诊断的酒精相关肝病或MetALD相关肝细胞癌患者一线治愈性治疗分配率为56%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alcohol-related liver disease is the third leading cause of hepatocellular carcinoma worldwide and the leading cause in Europe. Additionally, the recent definition of metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD) will enrich this population with a more nuanced phenotype, reflecting recent epidemiological trends. In these patients, the hepatocellular carcinoma diagnosis is often delayed and less frequently detected through screening programmes. Moreover, at the time of diagnosis, patients with alcohol-related hepatocellular carcinoma tend to have a poorer general condition, more severely impaired liver function, and a higher prevalence of comorbidities, leading to increased competitive mortality. However, when hepatocellular carcinoma is diagnosed during surveillance programmes in patients with alcohol-related liver disease or MetALD, the rate of allocation to first-line curative treatments is high (56%) and comparable to that of patients with virus-related hepatocellular carcinoma. As a consequence, the aetiology of the underlying cirrhosis cannot be considered an independent prognostic factor in patients with hepatocellular carcinoma. Instead, prognosis is driven by liver function, general condition, and tumour burden. This underscores the crucial role of early diagnosis through periodic surveillance in patients with alcohol- or MetALD-related cirrhosis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ganne-Carrié N, Nahon P. Differences between hepatocellular carcinoma caused by alcohol and other aetiologies. J Hepatol. 2024. PMID: 39710147. doi:10.1016/j.jhep.2024.12.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。